Anti-inflammatory hydrolysate of
View Patent ↗Methods and compositions for reducing and/or inhibiting inflammation by topical application of dermatocosmetic compositions comprising effective amounts of extracts of Coriolus versicolor that have been hydrolyzed by an acid protease, preferably Rhizomucor miehei , and thereafter rendered substantially devoid of acid-protease activity.
1. A method of reducing inflammation of skin in need thereof comprising topically applying to said skin an effective amount of an anti-inflammatory mushroom hydrolsate, wherein said mushroom hydrolysate is substantially devoid of acid protease activity, and wherein the mushroom hydrolysate is obtained by: (a) extracting water-soluble polysaccharopeptide constituents of Coriolus versicolor with acidic aqueous solvent having a pH of from about 3.5 to about 4.5 to provide a water-soluble polysaccharopeptide extract; (b) hydrolyzing the water-soluble polysaccharopeptide extract with an acid protease enzyme of Rhizomucor miehei ; and (c) inactivating the acid protease with a molecular weight sieve, by thermal inactivation, or by pepstatin-affinity gel chromatography.
2. The method of claim 1 , wherein the anti-inflammatory mushroom hydrolysate is applied to the skin in a dermatocosmetic composition, wherein said anti-inflammatory mushroom hydrolysate is present in the composition in an amount of from about 0.01% to about 10% by weight of the composition.
3. The method of claim 1 , wherein the acid protease enzyme of Rhizomucor miehei in step (b) has from about 4,000 to about 10,000 HUT units of activity per milliliter.
4. The method of claim 2 , wherein the dermatocosmetic composition further comprises at least one additional topical anti-inflammatory agent.
5. The method of claim 4 , wherein the at least one additional topical anti-inflammatory agent is selected from the group consisting of non-steroidal anti-inflammatory drug or a hydrocortisone.